18th Annual International Congress on Hematologic Malignancies®
Crowne Plaza
New York, NY
February 14 - 15, 2014
 
31st Annual Miami Breast Cancer Conference®
Fontainebleau Miami Beach
Miami Beach, FL
March 6 - 9, 2014
 
7th Annual Interdisciplinary Prostate Cancer Congress™ (IPCC®)
Corwne Plaza 
New York, NY
March 15, 2014
 
13th Annual International Congress on the Future of Breast Cancer®
Hyatt Regency
Huntington Beach, CA
July 17 - 19, 2014
 
15th Annual International Lung Cancer Congress®
Hyatt Regency
Huntington Beach, CA
July 31 - August 2, 2014

12th Annual International Congress on Targeted Therapies in Cancer®
New York, NY
October 2014

12th Annual School of Breast Oncology®
Emory University Conference Center
Atlanta, GA

November 6 - 9, 2014

9th Annual New York Lung Cancer Symposium®
New York
November 8, 2014




Upcoming AJMC events
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Matt Salo Explains the Impact Sovaldi Has on State Medicaid
Despite being used to dealing with drugs that are incredibly expensive, the high cost of Sovaldi presents a new problem for state Medicaid programs, according to Matt Salo, the executive director of the National Association of Medicaid Directors.
 
Alex Bastian Strives to Define Value in Care Better
In order to reign in high costs of care in oncology, the healthcare community needs to be able to define value better, according to Alex Bastian, MBA, senior vice president at GfK.
 
Dr Mark G. Kris on Use of the Patient’s Genome
Recent important changes in oncology have led to major advances that allow providers to recommend very specific therapies, said Mark G. Kris, MD, William and Joy Ruane chair in thoracic oncology at Memorial Sloan Kettering Cancer Center.
Episode 9 - Analyzing Incentive Programs
In this segment, the panelists analyze current programs that aim to educate and guide key stakeholders through the facets of cancer care and conclude that collaboration can help control costs and drive quality.